Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer (Q81311020)
Jump to navigation
Jump to search
scientific article published on 17 September 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer |
scientific article published on 17 September 2007 |
Statements
Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal cell cancer (English)
Ronald M Bukowski
Fairooz F Kabbinavar
Robert A Figlin
Keith Flaherty
Sandy Srinivas
Ulka Vaishampayan
Harry A Drabkin
Sarah Ryba
Qi Xia
Frank A Scappaticci
David McDermott
17 September 2007